SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Marasini, B.
Right arrow Articles by Agostoni, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marasini, B.
Right arrow Articles by Agostoni, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
*EPINEPHRINE
Medline Plus Health Information
*Raynaud's Disease
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Circulating Dopamine in Raynaud's Phenomenon

Bianca Marasini

Clinica Medica V, Ospedale S. Paolo, University of Milan, Milan, Italy

Maria Luisa Biondi

Clinica Medica V, Ospedale S. Paolo, University of Milan, Milan, Italy

Angelo Agostoni

Clinica Medica V, Ospedale S. Paolo, University of Milan, Milan, Italy

Plasma free and conjugated and intraplatelet free dopamine, norep inephrine, and epinephrine levels were determined by high-performance liquid chromatography coupled with electrochemical detection for 20 subjects with Raynaud's phenomenon of various etiologies.

Circulating free dopamine and epinephrine were significantly lower in Ray naud's patients than in controls (dopamine 26.0±13.6 vs 56.3+39.6 pg/ml, p<0.005; epinephrine 25.8±16.9 vs 56.9±40.9 pg/ml, p < 0.005), while the corresponding conjugated forms in plasma and the intraplatelet contents were within normal limits. There were no abnormalities in plasma free, conjugated, or intraplatelet free norepinephrine. All of the levels were independent of the etiology, the duration, and the severity of the disease.

The reduced plasma levels of free dopamine and epinephrine might be due to impaired adrenal release in response to some kinds of sympathetic stimulation or to rapid tissue uptake and peripheral metabolism. A possible role for a post- ischemic dopaminergic vasodilating system is discussed.

Angiology, Vol. 38, No. 12, 878-882 (1987)
DOI: 10.1177/000331978703801202
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement